![cbsn-fusion-aduhelm-alzheimers-drug-fda-approval-biogen-thumbnail-730045-640x360.jpg](https://assets2.cbsnewsstatic.com/hub/i/r/2021/06/07/ef9921ae-9adc-4e43-beb5-69f7afa5d2fa/thumbnail/640x360/a39fa18d252adb8e7b00d47c225e9f14/cbsn-fusion-aduhelm-alzheimers-drug-fda-approval-biogen-thumbnail-730045-640x360.jpg?v=5710b2ed1cee1bdfd30cb9c02455b43d#)
Study: New Alzheimer's diagnoses more common among seniors who have had COVID
A recent study of more than 6 million people 65 and older found that seniors who had Covid-19 had a substantially higher risk of being diagnosed with Alzheimer's disease within a year.